By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Investigators discuss new findings in Biotechnology. According to news reporting out of St. Louis, Missouri, by NewsRx editors, research stated, "Amyloid beta-peptide (A beta) plays a central role in the pathophysiology of Alzheimer's disease (AD) through the induction of oxidative stress. This peptide is produced by proteolytic cleavage of amyloid precursor protein (APP) by the action of beta- and gamma-secretases."
Our news journalists obtained a quote from the research from Veterans Affairs Medical Center, "Previous studies demonstrated that reduction of A beta, using an antisense oligonucleotide (AO) directed against the A beta region of APP, reduced oxidative stress-mediated damage and prevented or reverted cognitive deficits in senescence-accelerated prone mice (SAMP8), a useful animal model for investigating the events related to A beta pathology and possibly to the early phase of AD. In the current study, aged SAMP8 were treated by AO directed against PS-1, a component of the gamma-secretase complex, and tested for learning and memory in T-maze foot shock avoidance and novel object recognition. Brain tissue was collected to identify the decrease of oxidative stress and to evaluate the proteins that are differently expressed and oxidized after the reduction in free radical levels induced by A beta. We used both expression proteomics and redbx proteomics approaches. In brain of AO-treated mice a decrease of oxidative stress markers was found, and the proteins identified by proteomics as expressed differently or nitrated are involved in processes known to be impaired in AD."
According to the news editors, the research concluded: "Our results suggest that the treatment with AO directed against PS-1 in old SAMP8 mice reverses learning and memory deficits and reduces A beta-mediated oxidative stress with restoration to the normal condition and identifies possible pharmacological targets to combat this devastating dementing disease."
For more information on this research see: Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: A proteomics study. Free Radical Biology and Medicine, 2013;65():1-14. Free Radical Biology and Medicine can be contacted at: Elsevier Science Inc, 360 Park Ave South, New York, NY 10010-1710, USA. (Elsevier - www.elsevier.com; Free Radical Biology and Medicine - www.elsevier.com/wps/product/cws_home/525469)
Our news journalists report that additional information may be obtained by contacting A. Fiorini, VA Med Center, St Louis, MO, United States. Additional authors for this research include R. Sultana, S. Forster, M. Perluigi, G. Cenini, C. Cini, J. Cai, J.B. Klein, S.A. Farr, M.L. Niehoff, J.E. Morley, V.B. Kumar and D.A. Butterfield (see also technology.html">Biotechnology).
Keywords for this news article include: Antisense Technology, Biotechnology, Missouri, St. Louis, Proteomics, United States, Bioengineering, North and Central America
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC